KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Inventory Average (2016 - 2025)

Biomarin Pharmaceutical (BMRN) has disclosed Inventory Average for 16 consecutive years, with $1.3 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Inventory Average rose 11.16% year-over-year to $1.3 billion, compared with a TTM value of $1.3 billion through Dec 2025, up 11.16%, and an annual FY2025 reading of $1.3 billion, up 8.19% over the prior year.
  • Inventory Average was $1.3 billion for Q4 2025 at Biomarin Pharmaceutical, down from $1.4 billion in the prior quarter.
  • Across five years, Inventory Average topped out at $1.4 billion in Q3 2025 and bottomed at $706.2 million in Q1 2021.
  • Average Inventory Average over 5 years is $1.0 billion, with a median of $1.0 billion recorded in 2023.
  • The sharpest move saw Inventory Average grew 9.05% in 2021, then grew 23.84% in 2024.
  • Year by year, Inventory Average stood at $763.0 million in 2021, then rose by 13.59% to $866.8 million in 2022, then grew by 23.41% to $1.1 billion in 2023, then rose by 12.74% to $1.2 billion in 2024, then increased by 11.16% to $1.3 billion in 2025.
  • Business Quant data shows Inventory Average for BMRN at $1.3 billion in Q4 2025, $1.4 billion in Q3 2025, and $1.3 billion in Q2 2025.